Semalytix Blog

By Yannick Loonus On May 28, 2020

Semalytix’ and Boehringer Ingelheim’s innovative social media study on the parental experience around Crohn’s disease wins EphMRA award

A patient preference study of Crohn’s disease treatments, carried out by Semalytix and partner Boehringer Ingelheim, has won a...

( read )

By Matthias Hartung On May 4, 2020

At Semalytix, we are committed to supporting pharmaceutical companies in their endeavors concerning patient-focused drug...

( read )

By Melanie Senior On April 20, 2020

The behavior and responsiveness of all companies and brands during the coronavirus crisis will have a big impact on how they...

( read )